NBRV logo

Nabriva Therapeutics (NBRV) Operating Expenses

NBRV Annual Operating Expenses

$58.26 M
-$4.34 M-6.93%

31 December 2022

NBRV Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NBRV Quarterly Operating Expenses

$11.63 M
-$477.00 K-3.94%

31 March 2023

NBRV Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NBRV Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.9%-26.7%
3 y3 years-33.2%-43.2%
5 y5 years-21.0%-40.0%

NBRV Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-51.8%-78.0%

Nabriva Therapeutics Operating Expenses History

DateAnnualQuarterly
Mar 2023
-
$11.63 M(-3.9%)
Dec 2022
$58.26 M(-6.9%)
$12.10 M(-22.3%)
Sept 2022
-
$15.57 M(+5.8%)
June 2022
-
$14.72 M(-7.2%)
Mar 2022
-
$15.87 M(-4.0%)
Dec 2021
$62.60 M(-8.2%)
$16.53 M(+9.9%)
Sept 2021
-
$15.04 M(-3.1%)
June 2021
-
$15.51 M(-0.0%)
Mar 2021
-
$15.52 M(-22.2%)
Dec 2020
$68.22 M(-21.7%)
$19.94 M(+44.9%)
Sept 2020
-
$13.76 M(-2.0%)
June 2020
-
$14.04 M(-31.4%)
Mar 2020
-
$20.48 M(-8.0%)
Dec 2019
$87.17 M(-27.9%)
$22.27 M(-6.0%)
Sept 2019
-
$23.68 M(+12.9%)
June 2019
-
$20.98 M(+3.6%)
Mar 2019
-
$20.24 M(-34.4%)
Dec 2018
$120.88 M
$30.88 M(-41.7%)
Sept 2018
-
$52.92 M(+198.9%)
DateAnnualQuarterly
June 2018
-
$17.71 M(-8.6%)
Mar 2018
-
$19.36 M(-13.1%)
Dec 2017
$73.77 M(+34.0%)
$22.28 M(+7.5%)
Sept 2017
-
$20.73 M(+33.2%)
June 2017
-
$15.56 M(+2.4%)
Mar 2017
-
$15.20 M(+3.1%)
Dec 2016
$55.05 M(+98.3%)
$14.74 M(+4.7%)
Sept 2016
-
$14.08 M(+22.1%)
June 2016
-
$11.53 M(-21.6%)
Mar 2016
-
$14.70 M(+36.0%)
Dec 2015
$27.76 M(+159.5%)
$10.81 M(+29.5%)
Sept 2015
-
$8.35 M(+51.6%)
June 2015
-
$5.51 M(+77.9%)
Mar 2015
-
$3.10 M(-21.0%)
Dec 2014
$10.70 M(+58.7%)
$3.92 M(+103.9%)
Sept 2014
-
$1.92 M(-14.6%)
June 2014
-
$2.25 M(-13.6%)
Mar 2014
-
$2.60 M
Dec 2013
$6.74 M
-

FAQ

  • What is Nabriva Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Nabriva Therapeutics?
  • What is Nabriva Therapeutics annual operating expenses year-on-year change?
  • What is Nabriva Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Nabriva Therapeutics?
  • What is Nabriva Therapeutics quarterly operating expenses year-on-year change?

What is Nabriva Therapeutics annual total operating expenses?

The current annual operating expenses of NBRV is $58.26 M

What is the all time high annual operating expenses for Nabriva Therapeutics?

Nabriva Therapeutics all-time high annual total operating expenses is $120.88 M

What is Nabriva Therapeutics annual operating expenses year-on-year change?

Over the past year, NBRV annual total operating expenses has changed by -$4.34 M (-6.93%)

What is Nabriva Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of NBRV is $11.63 M

What is the all time high quarterly operating expenses for Nabriva Therapeutics?

Nabriva Therapeutics all-time high quarterly total operating expenses is $52.92 M

What is Nabriva Therapeutics quarterly operating expenses year-on-year change?

Over the past year, NBRV quarterly total operating expenses has changed by -$4.24 M (-26.72%)